Compare Micron Technology, Inc. (MU) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Micron Technology, Inc. vs Summit Therapeutics Inc — how do they compare? Micron Technology, Inc. trades at $987 (market cap $977.44B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Micron Technology, Inc. is far larger — about 93.3× Summit Therapeutics Inc's market cap, and Micron Technology, Inc. pays a 0.06% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| MU | SMMT | |
|---|---|---|
Market Cap | $977.44B | $10.48B |
Sector | Technology | Health |
52-Week High | $1.21K | $29.32 |
52-Week Low | $104.88 | $13.05 |
Enterprise Value | $957.80B | $9.90B |
Dividend Yield | 0.06% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Micron Technology, Inc.
Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
